跳至主要内容
临床试验/NCT05736354
NCT05736354招募中不适用

Molecular Mechanisms Associated With Breast Implant Complications

Indiana University6 个研究点 分布在 1 个国家目标入组 1,000 人开始时间: 2021年1月3日最近更新:
适应症

试验速览

阶段
不适用
状态
招募中
入组人数
1,000
试验地点
6
主要终点
Presence of Biofilm in Breast Tissue

研究概览

简要总结

Bacterial biofilms cause implant failures, chronic inflammation, and immune polarization. The study investigates the possible role of bacterial biofilm as a factor in the etiology of Breast Implant Illness. Three patient cohorts will be studied (A) Subjects with breast implant with BII manifestations (B) Subjects with breast implants without BII manifestations (C) Subjects without breast implants who underwent breast surgery procedure. Blood, surgically discarded tissue, implants, and associated capsules will be collected through this protocol.

详细描述

Breast implants were first introduced in 1962. It is estimated that 10 million women worldwide, including three million Americans have breast implants. There has been increased identification of patients experiencing a constellation of symptoms related to their implants. For breast implants, these symptoms are often associated with autoimmune and connective tissue disorders (CTD) and have been referred to as Breast Implant Illness (BII). A growing number of patients 30,000 annually are seeking to have their breast implants removed. In view of the implant associated complications, the US Food and Drug Administration (FDA) has placed a black box warning on breast implants. Limited research has resulted in a void in the prognosis of this surgical problem. Bacterial biofilms are becoming a major concern for medical device implants. Bacterial biofilms cause implant failures, chronic inflammation, and immune polarization. The study investigates the possible role of bacterial biofilm as a factor in the etiology of BII.

This research studies oxilidized lipids (oxylipins). These are metabolities formed as a result of host-biofilm interaction. The presence of oxylipins will be studied in peri-prosthetic tissue post-biofilm infection and in systemic circulation. Oxylipins are immunogenic. Hence, the investigators will also study the abundance of immune cells T cells and macrophages (types and subtypes) and associated cytokines.

研究设计

研究类型
Observational
观察模型
Case Control
时间视角
Cross Sectional

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
Female
接受健康志愿者

入选标准

  • for breast implant subjects:
  • Age greater than or equal to 18 years
  • Undergoing removal of breast implant
  • Willing and able to comply with protocol instructions
  • Inclusion Criteria for subjects undergoing breast surgeries (other than implant removal)
  • Age greater than or equal to 18 years
  • Undergoing breast surgery
  • Willing and able to comply with protocol instructions

排除标准

  • Individuals who are deemed unable to understand the procedures, risks, and benefits of the study, (i.e., unable to provide informed consent)
  • Pregnant females
  • Immunodeficiency (HIV/AIDS, SCID)
  • Currently on immunosuppressive medications
  • Prisoners

结局指标

主要结局

Presence of Biofilm in Breast Tissue

时间窗: Through study completion, an average of 1 year

During a clinically scheduled breast surgery, breast tissue specimens will be taken from surgically discarded tissue. The specimens from both breast implant subjects and control subjects (those undergoing breast surgery for a reason other than implant removal) will be analyzed to determine the presence of bacterial biofilm.

Analysis of host-biofilm interaction mediated oxylipins from blood

时间窗: Through study completion, an average of 1 year

Prior to a clinically scheduled breast surgery, 20 milliliters of blood will be collected during the pre-operative surgical preparations. The blood samples from both breast implant subjects and control subjects (those undergoing breast surgery for a reason other than implant removal) will be analyzed for host-biofilm interaction mediated oxylipins.

Cytokine analysis will be performed on breast tissue

时间窗: Through study completion, an average of 1 year

During a clinically scheduled breast surgery, breast tissue specimens will be taken from surgically discarded tissue. The specimens from both breast implant subjects and control subjects (those undergoing breast surgery for a reason other than implant removal) will undergo cytokine analysis.

Analysis of host-biofilm interaction mediated oxylipins from breast tissue

时间窗: Through study completion, an average of 1 year

During a clinically scheduled breast surgery, breast tissue specimens will be taken from surgically discarded tissue. The specimens from both breast implant subjects and control subjects (those undergoing breast surgery for a reason other than implant removal) will undergo oxylipin analysis.

次要结局

  • CD4+ Immunological Activation due to Host Implant Interaction(Through study completion, an average of 1 year)

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Mithun Sinha

Assistant Professor

Indiana University

研究点 (6)

Loading locations...

相似试验